$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
RET突变甲状腺髓样癌患者治疗希望-塞尔帕替尼
2025-10-19 11:44:20
Check Details
塞尔帕替尼(Retevmo)对晚期RET融合阳性甲状腺癌患者的疗效
2025-10-19 11:44:20
Check Details
塞尔帕替尼(Retevmo)国内哪里能买到?多少钱一盒?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗局部放射性碘难治性分化型甲状腺癌疗效如何?2分钟即可了解
2025-10-19 11:44:20
Check Details
如何正确应对甲状腺癌患者服用仑伐替尼的副作用?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET突变型甲状腺髓样癌的疗效和安全性
2025-10-19 11:44:20
Check Details
【正确服药】仑伐替尼在甲状腺癌中最正确的用法用量是多少?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET阳性甲状腺癌的效果和副作用
2025-10-19 11:44:20
Check Details
【关注】2021年塞尔帕替尼医保会给予报销吗?
2025-10-19 11:44:20
Check Details
【疗效看这里】仑伐替尼治疗甲状腺癌效果
2025-10-19 11:44:20
Check Details
RET基因变异靶向药塞尔帕替尼图片及说明
2025-10-19 11:44:20
Check Details
塞尔帕替尼在受过卡博替尼或凡德他尼治疗的RET突变型甲状腺髓样癌中的应用
2025-10-19 11:44:20
Check Details
1
2
...
2532
2533
2534
2535
2536
2537
2538
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
2
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
7
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
8
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
9
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
10
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
11
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
12
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments